322 related articles for article (PubMed ID: 25670500)
41. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen.
Collis AV; Brouwer AP; Martin AC
J Mol Biol; 2003 Jan; 325(2):337-54. PubMed ID: 12488099
[TBL] [Abstract][Full Text] [Related]
42. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.
Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678
[TBL] [Abstract][Full Text] [Related]
43. Structural diversity in a human antibody germline library.
Teplyakov A; Obmolova G; Malia TJ; Luo J; Muzammil S; Sweet R; Almagro JC; Gilliland GL
MAbs; 2016; 8(6):1045-63. PubMed ID: 27210805
[TBL] [Abstract][Full Text] [Related]
44. Dead-end elimination with backbone flexibility.
Georgiev I; Donald BR
Bioinformatics; 2007 Jul; 23(13):i185-94. PubMed ID: 17646295
[TBL] [Abstract][Full Text] [Related]
45. A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity.
Timmerman P; Barderas R; Desmet J; Altschuh D; Shochat S; Hollestelle MJ; Höppener JW; Monasterio A; Casal JI; Meloen RH
J Biol Chem; 2009 Dec; 284(49):34126-34. PubMed ID: 19808684
[TBL] [Abstract][Full Text] [Related]
46. Computational Tools for Aiding Rational Antibody Design.
Krawczyk K; Dunbar J; Deane CM
Methods Mol Biol; 2017; 1529():399-416. PubMed ID: 27914064
[TBL] [Abstract][Full Text] [Related]
47. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
[TBL] [Abstract][Full Text] [Related]
48. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
49. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
50. Homology Modeling of Antibody Variable Regions: Methods and Applications.
Bansia H; Ramakumar S
Methods Mol Biol; 2023; 2627():301-319. PubMed ID: 36959454
[TBL] [Abstract][Full Text] [Related]
51. An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics.
Lee DCP; Raman R; Ghafar NA; Budigi Y
Antiviral Res; 2021 Aug; 192():105105. PubMed ID: 34111505
[TBL] [Abstract][Full Text] [Related]
52. Antibodies as a model system for comparative model refinement.
Sellers BD; Nilmeier JP; Jacobson MP
Proteins; 2010 Aug; 78(11):2490-505. PubMed ID: 20602354
[TBL] [Abstract][Full Text] [Related]
53. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
54. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
Rouet R; Dudgeon K; Christie M; Langley D; Christ D
J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
[TBL] [Abstract][Full Text] [Related]
55. Rosetta FunFolDes - A general framework for the computational design of functional proteins.
Bonet J; Wehrle S; Schriever K; Yang C; Billet A; Sesterhenn F; Scheck A; Sverrisson F; Veselkova B; Vollers S; Lourman R; Villard M; Rosset S; Krey T; Correia BE
PLoS Comput Biol; 2018 Nov; 14(11):e1006623. PubMed ID: 30452434
[TBL] [Abstract][Full Text] [Related]
56. Highly active enzymes by automated combinatorial backbone assembly and sequence design.
Lapidoth G; Khersonsky O; Lipsh R; Dym O; Albeck S; Rogotner S; Fleishman SJ
Nat Commun; 2018 Jul; 9(1):2780. PubMed ID: 30018322
[TBL] [Abstract][Full Text] [Related]
57. Contributions of the complementarity determining regions to the thermal stability of a single-domain antibody.
Zabetakis D; Anderson GP; Bayya N; Goldman ER
PLoS One; 2013; 8(10):e77678. PubMed ID: 24143255
[TBL] [Abstract][Full Text] [Related]
58. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
59. Combining Rosetta with molecular dynamics (MD): A benchmark of the MD-based ensemble protein design.
Ludwiczak J; Jarmula A; Dunin-Horkawicz S
J Struct Biol; 2018 Jul; 203(1):54-61. PubMed ID: 29454111
[TBL] [Abstract][Full Text] [Related]
60. Predicting antibody complementarity determining region structures without classification.
Choi Y; Deane CM
Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
